Literature DB >> 2241411

Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat.

O Z Chi1, P Pollak, H R Weiss.   

Abstract

The effects of magnesium sulfate and nifedipine on regional cerebral blood flow were compared after ligation of the middle cerebral artery in rats. Twenty-one rats were divided into 3 groups of 7 each. The groups were the magnesium group, the nifedipine group, and the control group. Animals were anesthetized with pentobarbital. The middle cerebral artery was ligated, and magnesium sulfate was infused at a rate of 16 mg/kg/min for 30 min in the magnesium group, and nifedipine was infused at a rate of 10 micrograms/kg/min for 45 min in the nifedipine group. Using [14C]-iodoantipyrine, regional cerebral blood flow was measured 1 hr after middle cerebral artery ligation in the ischemic cortex, contralateral cortex, thalamus, hypothalamus, pons, medulla and cerebellum. In the control group, the mean cerebral blood flow was 30.7 +/- 12.2 ml/min/100 g in the middle cerebral artery-ligated cortex, and 75.9 +/- 10.5 ml/min/100 g in the contralateral cortex. Nifedipine did not significantly alter the cerebral blood flow in any of the brain regions studied. However, in the magnesium group, the regional cerebral blood flow in the middle cerebral artery-ligated cortex was significantly higher (64.2 +/- 8.8 ml/min/100 g) than that recorded in the control and nifedipine groups, whereas the regional cerebral blood flow in the contralateral cortex was not significantly different from other groups. Our data showed that magnesium was effective and superior to nifedipine in improving blood flow in the ischemic area of the brain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2241411

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  12 in total

1.  The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage.

Authors:  Abutaher M Yahia; Jawad F Kirmani; Adnan I Qureshi; Lee R Guterman; L Nelson Hopkins
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 2.  Magnesium neuroprotection is limited in humans with acute brain injury.

Authors:  J Andrew McKee; Randall P Brewer; Gary E Macy; Cecil O Borel; James D Reynolds; David S Warner
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 3.  Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness.

Authors:  K W Muir
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Assessment of the effects of endothelin-1 and magnesium sulphate on regional blood flows in conscious rats, by the coloured microsphere reference technique.

Authors:  P A Kemp; S M Gardiner; J E March; P C Rubin; T Bennett
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 5.  Investigational therapies for ischemic stroke: neuroprotection and neurorecovery.

Authors:  Preeti Sahota; Sean I Savitz
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 6.  Neuroprotection in Acute Ischemic Stroke: A Battle Against the Biology of Nature.

Authors:  Sherief Ghozy; Abdullah Reda; Joseph Varney; Ahmed Sallam Elhawary; Jaffer Shah; Kimberly Murry; Mohamed Gomaa Sobeeh; Sandeep S Nayak; Ahmed Y Azzam; Waleed Brinjikji; Ramanathan Kadirvel; David F Kallmes
Journal:  Front Neurol       Date:  2022-05-31       Impact factor: 4.086

7.  Magnesium sulphate only slightly reduces the shivering threshold in humans.

Authors:  A Wadhwa; P Sengupta; J Durrani; O Akça; R Lenhardt; D I Sessler; A G Doufas
Journal:  Br J Anaesth       Date:  2005-03-04       Impact factor: 9.166

Review 8.  Magnesium in stroke treatment.

Authors:  K W Muir
Journal:  Postgrad Med J       Date:  2002-11       Impact factor: 2.401

9.  Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery.

Authors:  Joseph P Mathew; William D White; David B Schinderle; Mihai V Podgoreanu; Miles Berger; Carmelo A Milano; Daniel T Laskowitz; Mark Stafford-Smith; James A Blumenthal; Mark F Newman
Journal:  Stroke       Date:  2013-10-08       Impact factor: 7.914

10.  Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trial.

Authors:  Andrew Bradford; Kennedy Lees
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.